norethindrone has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeng, MH; Jordan, VC | 1 |
Andersen, TO; Eilertsen, AL; Høibraaten, E; Os, I; Sandset, PM; Sandvik, L | 1 |
1 trial(s) available for norethindrone and transforming growth factor beta
Article | Year |
---|---|
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; C-Reactive Protein; Drug Combinations; Estradiol; Estriol; Female; Hormone Replacement Therapy; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; P-Selectin; Risk Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2005 |
1 other study(ies) available for norethindrone and transforming growth factor beta
Article | Year |
---|---|
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Estradiol; Gene Expression Regulation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 1991 |